Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the Mac Project

Extended-phase anticoagulation with direct oral Xa inhibitors (OAXI) is suggested in patients with cancer-associated venous thromboembolism (CAT). We report on patients enrolled in the MAC (Monitoring AntiCoagulants) Project, given rivaroxaban as extended-phase anticoagulation after CAT. The primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernardi, Enrico, Camporese, Giuseppe, Bortoluzzi, Cristiano, Noventa, Franco, Ceccato, Davide, Tonello, Chiara, Vohong, Stefania, Campello, Elena, Simion, Chiara, Imbalzano, Egidio, Di Micco, Pierpaolo, Callegari, Elena, Simioni, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699076/
https://www.ncbi.nlm.nih.gov/pubmed/36362880
http://dx.doi.org/10.3390/life12111725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699076/
https://www.ncbi.nlm.nih.gov/pubmed/36362880
http://dx.doi.org/10.3390/life12111725

Ejemplares similares